Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
Trade this ETF at your broker
Index | Solactive Pharma Breakthrough Value |
Investment focus | Equity, World, Health Care |
Fund size | EUR 19 m |
Total expense ratio | 0.49% p.a. |
Replication | Physical (Full replication) |
Legal structure | ETF |
Strategy risk | Long-only |
Sustainability | No |
Fund currency | USD |
Currency risk | Currency unhedged |
Volatility 1 year (in EUR) | 16.84% |
Inception/ Listing Date | 23 January 2018 |
Distribution policy | Accumulating |
Distribution frequency | - |
Fund domicile | Ireland |
Fund Provider | Legal & General (LGIM) |
Fund Structure | Open-ended Investment Company (OEIC) |
UCITS compliance | Yes |
Administrator | BNY Mellon Fund Services (Ireland) Designated Activity Company |
Investment Advisor | Legal & General Investment Management Limited |
Custodian Bank | BNY Mellon Trust Company (Ireland) Limited |
Revision Company | EY |
Fiscal Year End | 30 June |
Swiss representative | State Street |
Swiss paying agent | State Street Bank International GmbH, München, Zweigniederlassung Zürich |
Tax data | Bundesanzeiger | |
Germany | 30% tax rebate | |
Switzerland | No ESTV Reporting | |
Austria | Tax Reporting Fund | |
UK | UK Reporting |
Indextype | Total return index |
Swap counterparty | - |
Collateral manager | BNY Mellon Fund Services (Ireland) Limited |
Securities lending | No |
Securities lending counterparty |
Xeris Biopharma Holdings | 3.59% |
BeOne Medicines Ltd. | 3.09% |
Alnylam Pharmaceuticals | 3.07% |
Catalyst Pharmaceuticals, Inc. | 3.06% |
Halozyme Therapeutics | 2.90% |
Pharming Group | 2.84% |
Bristol Myers Squibb Co. | 2.81% |
Johnson & Johnson | 2.80% |
BioMarin Pharmaceutical | 2.76% |
Vertex Pharmaceuticals | 2.76% |
Health Care | 85.93% |
Basic Materials | 5.27% |
Other | 8.80% |
Broker | Rating | Execution fee | Account fee | |
---|---|---|---|---|
![]() | 0.00€ | 0.00€ | View offer* | |
![]() | 0.00€ | 0.00€ | View offer* | |
![]() | 0.00€ | 0.00€ | View offer* | |
![]() | 0.00€ | 0.00€ | View offer* | |
![]() | 0.00€ | 0.00€ | View offer* |
Broker | Rating | Order fee | ETF savings plans | |
---|---|---|---|---|
![]() | 0.99€ | 2727 | View offer* | |
![]() | 0.00€ | 1459 | View offer* | |
![]() | 1.00€ | 2411 | View offer* | |
![]() | 0.00€ | 1639 | View offer* | |
![]() | 0.00€ | 1687 | View offer* |
YTD | -1.25% |
1 month | +3.38% |
3 months | -3.95% |
6 months | -2.87% |
1 year | +5.45% |
3 years | -1.35% |
5 years | -5.48% |
Since inception (MAX) | +17.33% |
2024 | +1.27% |
2023 | -13.42% |
2022 | -1.53% |
2021 | +4.12% |
Volatility 1 year | 16.84% |
Volatility 3 years | 16.68% |
Volatility 5 years | 16.85% |
Return per risk 1 year | 0.32 |
Return per risk 3 years | -0.03 |
Return per risk 5 years | -0.07 |
Maximum drawdown 1 year | -19.94% |
Maximum drawdown 3 years | -25.60% |
Maximum drawdown 5 years | -28.26% |
Maximum drawdown since inception | -28.95% |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
gettex | EUR | ETLI | - - | - - | - |
Borsa Italiana | EUR | BIOT | BIOT IM ETLIEUIV | ECBIOT.MI ETLIEURINAV=SOLA | Flow Traders B.V. |
Euronext Amsterdam | EUR | BIOT | BIOT NA ETLIEUIV | GOBIOT.AS ETLIEURINAV=SOLA | Flow Traders B.V. |
London Stock Exchange | GBX | BIGT | BIGT LN NA | BIGT.L NA | Flow Traders B.V. |
London Stock Exchange | USD | BIOT | BIOT LN NA | GEBIOT.L NA | Flow Traders B.V. |
SIX Swiss Exchange | CHF | BIOT | BIOT SW ETLIEUIV | BIOTC.S ETLIEURINAV=SOLA | Flow Traders B.V. |
XETRA | EUR | ETLI | ETLI GY ETLIEUIV | ETLI.DE ETLIEURINAV=SOLA | Flow Traders B.V. |
Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
---|---|---|---|---|
iShares Healthcare Innovation UCITS ETF | 815 | 0.40% p.a. | Accumulating | Sampling |
L&G Healthcare Breakthrough UCITS ETF USD Acc | 60 | 0.49% p.a. | Accumulating | Full replication |
Harbor Health Care UCITS ETF Accumulating | 15 | 0.89% p.a. | Accumulating | Full replication |
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C 1C | 5 | 0.30% p.a. | Accumulating | Full replication |
VanEck Genomics and Healthcare Innovators UCITS ETF A | 4 | 0.35% p.a. | Accumulating | Full replication |